Feature
Article
Lawrence M. Blatt on Taking the Leap from Scientist to Founder
Author(s):
Key Takeaways
- Lawrence M. Blatt emphasizes the importance of a cohesive team with decades of experience in viral diseases at Aligos Therapeutics.
- Aligos Therapeutics focuses on diseases causing significant harm, leveraging the team's extensive expertise in viral diseases.
The Aligos Therapeutics chairman, president, and CEO discusses his journey to building his own company and bringing an experienced team along with him.
Chairman, president, and CEO Lawrence M. Blatt discusses the formation of his latest venture, Aligos Therapeutics, in this interview with Pharmaceutical Executive. The team at Aligos includes people who have worked with Blatt at multiple companies throughout his career. He describes it as a team that knows how to work together and has decades of experience in viral diseases, which drives their current focus on diseases that cause extreme harm to patients.
1:00 – A journey from being one of the earliest employees at a major biotech to founding and leading multiple ventures.
5:13 - Taking the leap from being a scientist to founder.
7:12 – The moments that stand out the most.
8:57 – The mission at Aligos Therapeutics.
14:35 – Raising capital in a difficult period.
16:49 – Building a team and a winning culture.
20:19 – Where the opportunities for innovation and disruption lay.
22:55 – What future biotech leaders should know.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
